Equashield Equashield Syringe Unit (UDI 07290013484079)Recalls & reported problems
Equashield Medical Ltd · Class 2
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07290013484079), received between Nov 12, 2020 and Mar 16, 2021 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Fluid/Blood Leak1
- Incomplete or Inadequate Connection1
Patient problems
- Insufficient Information1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 16, 2021Fluid/Blood Leak
THE NURSE WANTED TO ADMINISTER THE DOXORUBICIN (ADRIAMYCIN) IT STARTED TO LEAK FROM THE EQUASHIELD SYRINGE FROM THE TIP AND FROM THE ADAPTER. A 60 MG SYRINGE, LOT NUMBER IS 206001A, EXPIRATION 01/12/2023, NDC 07290013484079. FDA SAFETY REPORT ID# (B)(4).
Patient problems: Insufficient Information
MAUDE report 11505835 ↗MalfunctionNov 12, 2020Incomplete or Inadequate Connection
TRANSFER DEVICE NOT CONNECTING PROPERLY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 10828686 ↗
Other Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System devices
- BD PhaSeal 515003BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall183 reports
- BD PhaSeal 515056BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall159 reports
- BD PhaSeal Optima 515070BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall154 reports
- Alaris 10012241-0500BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall138 reports
- BD PhaSeal 515005BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall128 reports
- ICU Medical CL3011Icu Medical, Inc. · Closed antineoplastic and hazardous drug reconstitution and transfer system3 recalls26 reports
- BD PhaSeal Optima 515052BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall114 reports
- ICU Medical CL3511Icu Medical, Inc. · Closed antineoplastic and hazardous drug reconstitution and transfer system3 recalls6 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.